National and Kapodistrian University of Athens
Analysis of collagen and its peptides in chronic diseases
Abstract
dc:descriptionTissues consist of two major components: cells and the extracellular matrix (ECM). The latter is involved in structural integrity; regulating cell phenotype, proliferation, survival and migration; and maintaining tissue homeostasis. Of particular interest in the ECM are collagens, a family of 28 proteins, with a common triple helix left-handed polyproline II motif formed by three polypeptide chains (α chains) consisting of Gly-X-Y repeats (with X frequently being a proline and Y frequently a hydroxyproline). This PhD thesis focuses on the ECM protein found in greater abundance and largely involved in pathological conditions, type I collagen (COL (I)), which consists of two collagen type I alpha 1 (COLα1 (I)) chains and one collagen type I alpha 2 (COLα2 (I)) chain 3. COL (I) is actively involved in fibrosis, a common denominator in chronic diseases characterised by excessive ECM accumulation in tissues. Fibrosis is, as mentioned before, distinguished by an imbalance in ECM production, mostly by fibroblasts, and ECM degradation, particularly of collagens, and can occur in multiple organs. Many diseases are associated with fibrosis and inappropriate wound healing. Taking into account that 1 in 60 of the global population develops heart fibrosis, 1 in 4 develops liver fibrosis, and 1 in 6 develops renal fibrosis; that fibrosis ultimately leads to organ failure requiring transplantation; as well as a lack of treatment options other than organ transplantation, the molecular mechanisms of fibrosis are of clinical interest. Improved understanding of such mechanisms can be used in drug repurposing strategies (finding alternative uses for existing drugs, which reduces expenses and risks to bring the drug to the market, and speeds up this process). Mass spectrometry-based proteomics offers an unbiased view of disease-associated changes on the proteome level. Considering the involvement of ECM proteins in fibrosis, these are of specific interest; however, their identification and quantification using mass spectrometry is hindered by their low abundance. Therefore, in this thesis, we investigated the benefits and limits of a decellularization protocol, removing the more abundant cellular proteins which can mask the less abundant ECM proteins, followed by proteomics analysis of the tissue. Moreover, we performed a comprehensive analysis of fibrotic tissue, identifying common proteins between fibrosis in different organs, investigating the affected pathways and proposing new compounds that may aid in the treatment of fibrosis.COLα1 (I) itself induces signalling pathways through binding of various receptors, including integrin β1, Endo180, Discoidin Domain Receptor (DDR), Leukocyte-associated immunoglobulin-like receptor-1 (LAIR-1), C-X-C chemokine receptor (CXCR) 4 and CXCR2. Matrix-metalloproteinases (MMPs) and cathepsins are prominently involved in the degradation of ECM proteins, including collagens. This degradation generates peptides, some of which exhibit biological activity and are termed “matrikines”. These matrikines can circulate in blood and are detectable in urine. Their identification is facilitated by technologies such as capillary electrophoresis coupled with mass spectrometry (CE-MS), a robust and reproducible high-throughput method. The biological activities of collagen-derived matrikines include, among others, ECM deposition, collagen synthesis, chemoattraction, proliferation, and inflammation. Specific motifs on these peptides, such as the DGEA motif, the GUXGEZ motif (where U is usually hydrophobic, X usually hydroxyproline, and Z is often arginine), and the PGP motif have been extensively studied and have been shown to induce cell signalling and induce specific cellular activity. However, in most of these studies, synthetic peptides containing such motifs were used at high concentrations. Naturally occurring collagen-derived peptides have been associated with conditions such as kidney, cardiovascular and liver diseases, and have been proposed as biomarkers for these disorders. Therefore, the investigation of the biological effect of such peptides is relevant to better understand these increasingly prevalent diseases. These diseases often involve compromised endothelial function and are characterised by the presence of fibrosis, which is distinguished by an imbalance in ECM production (mostly by fibroblasts) and ECM degradation. Understanding how abundant collagen peptides influence endothelial cells and fibroblasts is therefore biologically relevant and may reveal mechanisms through which these peptides impact vascular health and disease progression. Therefore, we investigated the impact of specific peptides derived from COLα1 (I) on endothelial cells and fibroblasts.
Degree
thesis:*- Grantor dc:publisher
- National and Kapodistrian University of Athens
- Year dc:date
- 2026
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Devos, Hanne
- Δεβός, Χάννε
Subjects
dc:subject × 14Rights
- Language dc:language
- eng
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/61285